🔗 Visit the ClinicalTrials.gov page for NCT02584829
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. | BMC Med | 2016 | 0.83 |
| 2 | Trial Watch: Immunotherapy plus radiation therapy for oncological indications. | Oncoimmunology | 2016 | 0.81 |